<DOC>
	<DOCNO>NCT02591563</DOCNO>
	<brief_summary>The purpose study assess effectiveness Prevnar 13 pneumococcal acute otitis medium .</brief_summary>
	<brief_title>Acute Otitis Media Nasopharyngeal Colonization Caused Vaccine Serotypes Strep Pneumoniae Healthy Children</brief_title>
	<detailed_description>A prospective evaluation serotypes antibiotic susceptibility pneumococcus colonize nasopharynx cause acute otitis medium year 2015-2019 . The goal recruit child prospective group begin 6 month age follow 36 month age suburban Rochester , New York . Nasopharyngeal oropharyngeal swab obtain well child visit acute otitis medium episode . Middle ear fluid obtain every child every acute otitis medium episode . Children otitis prone invite join prospective group thereafter ( experience date suggest 60 % continue prospective follow ) . All nasopharyngeal middle ear fluid sample collect tested standard microbiologic technique identify presence 5 potential otopathogens ( S. pneumoniae , nontypeable Haemophilus influenzae , M. catarrhalis , Alloiococcus otitidis . All S. pneumoniae undergo antibiotic susceptibility test . All samples culture negative evaluate multi-locus PCR test examine presence 5 potential otopathogens .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<criteria>Male female age &lt; 407 day less than/equal 36 month old meet recurrent acute otitis medium criteria Child receive full ( 3 dose ) infant series Prevnar 13 Parent/guardian willing bring study visit Any major illness/condition investigator opinion would put subject risk study . Participation another investigational/interventional trial within 28 day prior study . ( Observational study permit ) Direct descendant study site personnel .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>36 Months</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>